Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Agape ATP Corporation stock logo
ATPC
Agape ATP
$1.31
-2.6%
$1.34
$0.90
$3.49
$65.51M-0.9849,020 shs28,022 shs
CORBF
Global Cord Blood
$1.05
$1.02
$0.25
$1.75
$127.63M-0.692,256 shsN/A
DocGo Inc. stock logo
DCGO
DocGo
$1.56
-4.3%
$1.54
$1.23
$5.68
$152.58M0.97487,863 shs425,897 shs
Exagen Inc. stock logo
XGN
Exagen
$9.86
+1.2%
$8.13
$2.38
$10.34
$216.92M1.6226,311 shs128,870 shs
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Agape ATP Corporation stock logo
ATPC
Agape ATP
0.00%-0.76%-2.67%-17.77%-48.63%
CORBF
Global Cord Blood
0.00%-32.26%+47.89%+5.00%-30.00%
DocGo Inc. stock logo
DCGO
DocGo
0.00%-9.30%+17.29%+4.70%-58.73%
Exagen Inc. stock logo
XGN
Exagen
0.00%-2.38%+14.25%+38.10%+230.87%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Agape ATP Corporation stock logo
ATPC
Agape ATP
0.1593 of 5 stars
0.03.00.00.02.00.00.0
CORBF
Global Cord Blood
N/AN/AN/AN/AN/AN/AN/AN/A
DocGo Inc. stock logo
DCGO
DocGo
1.9402 of 5 stars
3.33.00.00.01.70.80.6
Exagen Inc. stock logo
XGN
Exagen
3.597 of 5 stars
2.51.00.04.53.22.50.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Agape ATP Corporation stock logo
ATPC
Agape ATP
0.00
N/AN/AN/A
CORBF
Global Cord Blood
0.00
N/AN/AN/A
DocGo Inc. stock logo
DCGO
DocGo
2.50
Moderate Buy$3.59130.13% Upside
Exagen Inc. stock logo
XGN
Exagen
3.00
Buy$11.2514.10% Upside

Current Analyst Ratings Breakdown

Latest ATPC, XGN, CORBF, and DCGO Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/21/2025
DocGo Inc. stock logo
DCGO
DocGo
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$1.45 ➝ $1.60
7/30/2025
Exagen Inc. stock logo
XGN
Exagen
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$10.00
7/30/2025
Exagen Inc. stock logo
XGN
Exagen
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$8.00 ➝ $11.00
7/30/2025
Exagen Inc. stock logo
XGN
Exagen
KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeSector Weight ➝ Overweight$12.00
7/23/2025
Exagen Inc. stock logo
XGN
Exagen
Craig Hallum
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$12.00
(Data available from 9/1/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Agape ATP Corporation stock logo
ATPC
Agape ATP
$1.32M49.63N/AN/A$0.48 per share2.73
CORBF
Global Cord Blood
$196.12M0.65$0.75 per share1.40N/A
DocGo Inc. stock logo
DCGO
DocGo
$616.55M0.25$0.42 per share3.69$3.09 per share0.50
Exagen Inc. stock logo
XGN
Exagen
$55.64M3.90N/AN/A$0.54 per share18.26
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Agape ATP Corporation stock logo
ATPC
Agape ATP
-$2.47M-$0.41N/AN/A-183.13%-20.32%-18.55%11/12/2025 (Estimated)
CORBF
Global Cord Blood
$79.04MN/A0.00N/AN/AN/AN/AN/A
DocGo Inc. stock logo
DCGO
DocGo
$19.99M-$0.19N/A19.50N/A-4.20%-3.26%-2.24%11/6/2025 (Estimated)
Exagen Inc. stock logo
XGN
Exagen
-$15.11M-$0.89N/AN/AN/A-28.85%-130.38%-34.69%11/11/2025 (Estimated)

Latest ATPC, XGN, CORBF, and DCGO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/13/2025Q2 2025
Agape ATP Corporation stock logo
ATPC
Agape ATP
N/A-$0.01N/A-$0.01N/AN/A
8/7/2025Q2 2025
DocGo Inc. stock logo
DCGO
DocGo
-$0.06-$0.11-$0.05-$0.11$77.58 million$80.42 million
7/29/2025Q2 2025
Exagen Inc. stock logo
XGN
Exagen
-$0.18-$0.18N/A-$0.21$16.25 million$17.20 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Agape ATP Corporation stock logo
ATPC
Agape ATP
N/AN/AN/AN/AN/A
CORBF
Global Cord Blood
N/AN/AN/AN/AN/A
DocGo Inc. stock logo
DCGO
DocGo
N/AN/AN/AN/AN/A
Exagen Inc. stock logo
XGN
Exagen
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Agape ATP Corporation stock logo
ATPC
Agape ATP
N/A
20.36
20.33
CORBF
Global Cord Blood
N/AN/AN/A
DocGo Inc. stock logo
DCGO
DocGo
N/A
2.36
2.36
Exagen Inc. stock logo
XGN
Exagen
1.06
4.95
4.95

Institutional Ownership

CompanyInstitutional Ownership
Agape ATP Corporation stock logo
ATPC
Agape ATP
0.01%
CORBF
Global Cord Blood
N/A
DocGo Inc. stock logo
DCGO
DocGo
56.44%
Exagen Inc. stock logo
XGN
Exagen
75.25%

Insider Ownership

CompanyInsider Ownership
Agape ATP Corporation stock logo
ATPC
Agape ATP
9.67%
CORBF
Global Cord Blood
0.50%
DocGo Inc. stock logo
DCGO
DocGo
3.80%
Exagen Inc. stock logo
XGN
Exagen
12.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
Agape ATP Corporation stock logo
ATPC
Agape ATP
4050.01 million45.17 millionNot Optionable
CORBF
Global Cord Blood
1,200121.55 millionN/ANot Optionable
DocGo Inc. stock logo
DCGO
DocGo
4,40797.81 million94.09 millionOptionable
Exagen Inc. stock logo
XGN
Exagen
22022.00 million19.23 millionOptionable

Recent News About These Companies

BTIG Sticks to Their Buy Rating for Exagen (XGN)
What is KeyCorp's Forecast for Exagen Q3 Earnings?
Exagen (XGN) Receives a Buy from Craig-Hallum
Exagen Inc. Reports Record Revenue Amidst Growth Challenges
Keybanc Upgrades Exagen (XGN)
Exagen Q2 Revenue Jumps 14 Percent
Exagen Inc. (XGN) Q2 2025 Earnings Call Transcript
Exagen Inc. Reports Strong Q2 2025 Results

New MarketBeat Followers Over Time

Media Sentiment Over Time

Agape ATP stock logo

Agape ATP NASDAQ:ATPC

$1.31 -0.04 (-2.60%)
Closing price 08/29/2025 03:50 PM Eastern
Extended Trading
$1.32 +0.01 (+0.46%)
As of 08/29/2025 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Agape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia. It offers four series of programs that consist of various services and products under the ATP Zeta Health Program, ÉNERGÉTIQUE, BEAUNIQUE, and E.A.T.S. names. The company's products include ATP1s Survivor Select that contains various essential nutrients required by the human body to maintain normal metabolism; ATP3 Ionized Cal-Mag, a calcium and magnesium minerals supplement; ATP4 Omega Blend, an oil blend that provides a bio-effective balance of essential fatty acids, omega 3, and omega 6; ATP5 BetaMaxx, a natural immune enhancer; AGN-Vege Fruit Fiber, a nutrition-based formulation for intestines and stomach; AGP1-Iron to improve iron deficiency anemia; and YFA-Young Formula, an anti-aging and youthful maintenance supplement. It also provides BEAUNIQUE brand products comprising Mito+, an antioxidant drink for cellular, immune, metabolic, brain, and skin health; and Trim+, which inhibits the activities of carbohydrates digestive enzymes that result in a reduction of the breakdown and absorption of sugars. In addition, the company offers energy masks, including N°1 Med-Hydration, N°2 Med-Whitening, and N°3 Med-Firming, as well as hyaluronic acid serum and mousse facial cleanser under ÉNERGÉTIQUE brand; and soy protein isolate powder, and an antioxidant under Livo5 brand name. Further, it sells health and wellness products; and promotes wellness and wellbeing lifestyle through online editorials, programs, events, and campaigns, as well as provides health therapies. The company was incorporated in 2016 and is headquartered in Kuala Lumpur, Malaysia.

Global Cord Blood NYSE:CORBF

$1.05 0.00 (0.00%)
As of 08/29/2025

Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2022, it operated three cord blood banks, including one in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd.

DocGo stock logo

DocGo NASDAQ:DCGO

$1.56 -0.07 (-4.29%)
Closing price 08/29/2025 04:00 PM Eastern
Extended Trading
$1.56 -0.01 (-0.32%)
As of 08/29/2025 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

DocGo Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home, offices, and other locations; event services, which include on-site healthcare support at sporting events and concerts; and total care management solutions comprising healthcare services and ancillary services, such as shelter. DocGo Inc. was founded in 2015 and is headquartered in New York, New York.

Exagen stock logo

Exagen NASDAQ:XGN

$9.86 +0.12 (+1.23%)
Closing price 08/29/2025 04:00 PM Eastern
Extended Trading
$9.86 0.00 (-0.05%)
As of 08/29/2025 04:09 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Exagen Inc. develops and commercializes various testing products under the AVISE brand in the United States. The company enables healthcare providers to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Its lead testing product is AVISE CTD that enables differential diagnosis for patients presenting with symptoms indicative of various connective tissue diseases (CTDs) and other related diseases with overlapping symptoms. The company offers AVISE Lupus that measures activation of the complement system by quantifying the level of B-cell C4d and erythrocyte bound C4d in the patient's blood; and AVISE APS, which consists of a panel of autoantibody tests that aids in the diagnosis and management of APS. In addition, it provides AVISE Vasculitis AAV, which utilizes a testing panel of individual analytes to provide physicians with results in the assessment and monitoring of anti-neutrophil cytoplasmic antibody associated vasculitis; AVISE SLE Prognostic, a panel of autoantibodies for assessing the potential for complications affecting the kidney, brain, and cardiovascular system; and AVISE Anti-CarP test, which identifies RA patients with severe disease. Further, the company offers AVISE SLE Monitor, a biomarker blood test; AVISE MTX, a patented and validated blood test; and AVISE HCQ, a blood test to monitor levels of hydroxychloroquine. It has a research collaboration and license agreement with Allegheny Health Network (AHN) Research Institute to develop novel patented biomarkers. The company was formerly known as Exagen Diagnostics, Inc. and changed its name to Exagen Inc. in January 2019. Exagen Inc. was incorporated in 2002 and is headquartered in Vista, California.